We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Plasma-based biofunctionalization of vascular implants

    Steven G Wise

    School of Molecular Bioscience, University of Sydney, NSW 2006, Australia; School of Molecular Bioscience G08, University of Sydney, NSW 2006, Australia

    The Heart Research Institute, Sydney, NSW 2042, Australia

    ,
    Anna Waterhouse

    Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115, USA

    ,
    Alexey Kondyurin

    School of Physics, University of Sydney, NSW 2006, Australia

    ,
    Marcela M Bilek

    School of Physics, University of Sydney, NSW 2006, Australia

    &
    Anthony S Weiss

    * Author for correspondence

    Bosch Institute, University of Sydney, Sydney, 2006, Australia.

    Charles Perkins Centre, University of Sydney, Sydney, 2006, Australia

    Published Online:https://doi.org/10.2217/nnm.12.161

    Polymeric and metallic materials are used extensively in permanently implanted cardiovascular devices and devices that make temporary but often prolonged contact with body fluids and tissues. Foreign body responses are typically triggered by host interactions at the implant surface, making surface modifications to increase biointegration desirable. Plasma-based treatments are extensively used to modify diverse substrates; modulating surface chemistry, wettability and surface roughness, as well as facilitating covalent biomolecule binding. Each aspect impacts on facets of vascular compatibility including endothelialization and blood contact. These modifications can be readily applied to polymers such as Dacron® and expanded polytetrafluoroethylene, which are widely used in bypass grafting and the metallic substrates of stents, valves and pacemaker components. Plasma modification of metals is more challenging given the need for coating deposition in addition to surface activation, adding the necessity for robust interface adhesion. This review examines the evolving plasma treatment technology facilitating the biofunctionalization of polymeric and metallic implantable cardiovascular materials.

    Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

    References

    • Mani G, Feldman MD, Patel D, Agrawal CM. Coronary stents: a materials perspective. Biomaterials28(9),1689–1710 (2007).
    • Bhuyan A, Gregory B, Lei H, Seow Yuen Yee, Gianchandani YB. Pulse and DC electropolishing of stainless steel for stents and other devices. Sensors, 2005 IEEE doi:10.1109/ICSENS.2005.1597699 (2005).
    • Werner C, Maitz MF, Sperling C. Current strategies towards hemocompatible coatings. J. Mater. Chem.17,3376–3384 (2007).
    • Wise SG, Byrom MJ, Waterhouse A, Bannon PG, Ng MK, Weiss AS. A multilayered synthetic human elastin/polycaprolactone hybrid vascular graft with tailored mechanical properties. Acta Biomater.7,295–303 (2011).
    • Singh R, Dahotre NB. Corrosion degradation and prevention by surface modification of biometallic materials. J. Mater. Sci. Mater. Med.18(5),725–751 (2007).
    • Sarkar S, Sales KM, Hamilton G, Seifalian AM. Addressing thrombogenicity in vascular graft construction. J. Biomed. Mater. Res. B82(1),100–108 (2007).
    • Lu J, Yao C, Yang L, Webster TJ. Decreased platelet adhesion and enhanced endothelial cell functions on nano and submicron-rough titanium stents. Tissue Eng. Part A18(13–14),1389–1398 (2012).
    • Seeger JM, Ingegno MD, Bigatan E et al. Hydrophilic surface modification of metallic endoluminal stents. J. Vasc. Surg.3,327–335; discussion 335–336 (1995).
    • Vogler EA. Structure and reactivity of water at biomaterial surfaces. Adv. Colloid Interface Sci.74,69–117 (1998).
    • 10  Palmaz JC, Bailey S, Marton D, Sprague E. Influence of stent design and material composition on procedure outcome. J. Vasc. Surg.5,1031–1039 (2002).
    • 11  Lau AK, Leichtweis SB, Hume P et al. Probucol promotes functional reendothelialization in balloon-injured rabbit aortas. Circulation107(15),2031–2036 (2003).
    • 12  Wu KK, Thiagarajan P. Role of endothelium in thrombosis and hemostasis. Annu. Rev. Med.47,315–331 (1996).
    • 13  Davies MG, Hagen P-O. The vascular endothelium. Ann. Surg.218(5),593– 609 (1993).
    • 14  Gutensohn K, Beythien C, Bau J et al.In vitro analyses of diamond-like carbon coated stents. Reduction of metal ion release, platelet activation, and thrombogenicity. Thromb. Res.99(6),577–585 (2000).
    • 15  Antoniucci D, Valenti R, Migliorini A et al. Clinical and angiographic outcomes following elective implantation of the Carbostent in patients at high risk of restenosis and target vessel failure. Catheter. Cardiovasc. Interv.54(4),420–426 (2001).
    • 16  Whelan DM, Van Der Giessen WJ, Krabbendam SC et al. Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries. Heart83(3),338–345 (2000).
    • 17  Bilek MM, McKenzie DR. Plasma modified surfaces for covalent immobilization of functional biomolecules in the absence of chemical linkers: towards better biosenors and a new generation of medical implants. Biophys. Rev.2,55–65 (2010).▪ Describes plasma process and deposition and includes discussion of mechanisms underpinning covalent attachment on treated surfaces.
    • 18  Ferrero VE, Andolfi L, Di Nardo G et al. Protein and electrode engineering for the covalent immobilization of p450 bmp on gold. Anal. Chem.80(22),8438–8446 (2008).
    • 19  Wyers MC, Phaneuf MD, Rzucidlo EM, Contreras MA, Logerfo FW, Quist WC. In vivo assessment of a novel dacron surface with covalently bound recombinant hirudin. Cardiovasc. Pathol.8(3),153–159 (1999).
    • 20  Biltresse S, Attolini M, Marchand-Brynaert J. Cell adhesive PET membranes by surface grafting of RGD peptidomimetics. Biomaterials26(22),4576–4587 (2005).
    • 21  Chollet C, Lazare S, Brouillaud B, Labrugere C, Bareille R, Durrieu MC. RGD peptide grafting onto micro-patterned PET: peptide distribution impact on cell attachment. J. Laser Micro. Nanoeng.1(3),226–230 (2006).
    • 22  Gabriel M, Dahm M, Vahl CF. Wet-chemical approach for the cell-adhesive modification of polytetrafluoroethylene. Biomed. Mater.6(3),035007 (2011).
    • 23  Dhahri M, Abed A, Lajimi RH et al. Grafting of dermatan sulfate on polyethylene terephtalate to enhance biointegration. J. Biomed. Mater. Res. A98(1),114–121 (2011).
    • 24  Lobb EJ, Ma I, Billingham NC, Armes SP, Lewis AL. Facile synthesis of well-defined, biocompatible phosphorylcholine-based methacrylate copolymers via atom transfer radical polymerization at 20 degrees C. J. Am. Chem. Soc.123(32),7913–7914 (2001).
    • 25  Larm O, Larsson R, Olsson P. A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. Biomat. Med. Dev. Art. Org.11(2–3),161–173 (1983).
    • 26  Udipi K, Ornberg RL, Thurmond KB 2nd, Settle SL, Forster D, Riley D. Modification of inflammatory response to implanted biomedical materials in vivo by surface bound superoxide dismutase mimics. J. Biomed. Mater. Res.51(4),549–560 (2000).
    • 27  Rezania A, Johnson R, Lefkow AR, Healy KE. Bioactivation of metal oxide surfaces. 1. Surface characterization and cell response. Langmuir15(20),6931–6939 (1999).
    • 28  Puleo DA. Activity of enzyme immobilized on silanized Co-Cr-Mo. J. Biomed. Mater. Res.29(8),951–957 (1995).
    • 29  Nanci A, Wuest JD, Peru L et al. Chemical modification of titanium surfaces for covalent attachment of biological molecules. J. Biomed. Mater. Res.40(2),324–335 (1998).
    • 30  Verheye S, Markou CP, Salame MY et al. Reduced thrombus formation by hyaluronic acid coating of endovascular devices. Atheroscer. Thromb. Vasc. Biol.20(4),1168–1172 (2000).
    • 31  Muller R, Abke J, Schnell E et al. Surface engineering of stainless steel materials by covalent collagen immobilization to improve implant biocompatibility. Biomaterials26(34),6962–6972 (2005).
    • 32  Thierry B, Winnik FM, Merhi Y, Griesser HJ, Tabrizian M. Biomimetic hemocompatible coatings through immobilization of hyaluronan derivatives on metal surfaces. Langmuir24(20),11834–11841 (2008).
    • 33  Ikada Y. Surface modification of polymers for medical applications. Biomaterials15(10),725–736 (1994).
    • 34  Chu PK, Chen JY, Wang LP, Huang N. Plasma-surface modification of biomaterials. Mater. Sci. Eng. R36(5–6),143–206 (2002).▪ Describes plasma techniques and methods and their historical development and specifically how these relate to biomedical device manufacture.
    • 35  Cheruthazhekatt S, Černák M, Slavíček P, Havel J. Gas plasmas and plasma modified materials in medicine. J. Appl. Biomed.8(2),55–66 (2010).
    • 36  Desmet T, Morent R, De Geyter N, Leys C, Schacht E, Dubruel P. Nonthermal plasma technology as a versatile strategy for polymeric biomaterials surface modification: a review. Biomacromolecules10(9),2351–2378 (2009).▪▪ Comprehensive review of plasma technology and its application to surfaces for biomaterial applications.
    • 37  Favia P, D’agostino R. Plasma treatments and plasma deposition of polymers for biomedical applications. Surf. Coat. Tech.98(1–3),1102–1106 (1998).
    • 38  Liu XY, Chu PK, Ding CX. Surface nano-functionalization of biomaterials. Mater. Sci. Eng. R70(3–6),275–302 (2010).
    • 39  Lewis F, Horny P, Hale P, Turgeon S, Tatoulian M, Mantovani D. Study of the adhesion of thin plasma fluorocarbon coatings resisting plastic deformation for stent applications. J. Appl. Phys. D41(4),045310 (2008).
    • 40  Gogolides E, Constantoudis V, Kokkoris G et al. Controlling roughness: from etching to nanotexturing and plasma-directed organization on organic and inorganic materials. J. Appl. Phys. D44(17),174021 (2011).
    • 41  Pareta RA, Reising AB, Miller T, Storey D, Webster TJ. Increased endothelial cell adhesion on plasma modified nanostructured polymeric and metallic surfaces for vascular stent applications. Biotech. Bioeng.103(3),459–471 (2009).
    • 42  Baldock C, Oberhauser AF, Ma L et al. Shape of tropoelastin, the highly extensible protein that controls human tissue elasticity. Proc. Natl. Acad. Sci. USA108(11),4322–4327 (2011).
    • 43  Loya MC, Brammer KS, Choi C, Chen LH, Jin S. Plasma-induced nanopillars on bare metal coronary stent surface for enhanced endothelialization. Acta Biomater.6(12),4589–4595 (2010).
    • 44  Dekker A, Reitsma K, Beugeling T, Bantjes A, Feijen J, Vanaken WG. Adhesion of endothelial-cells and adsorption of serum-proteins on gas plasma-treated polytetrafluoroethylene. Biomaterials12(2),130–138 (1991).
    • 45  Baquey C, Palumbo F, Porte-Durrieu MC, Legeay G, Tressaud A, D’agostino R. Plasma treatment of expanded PTFE offers a way to a biofunctionalization of its surface. Nucl. Instrum. Meth.B151(1–4),255–262 (1999).
    • 46  Pu FR, Williams RL, Markkula TK, Hunt JA. Effects of plasma treated PET and PTFE on expression of adhesion molecules by human endothelial cells in vitro. Biomaterials23(11),2411–2428 (2002).
    • 47  Shen Y, Wang G, Huang X et al. Surface wettability of plasma SiOx:H nanocoating-induced endothelial cells’ migration and the associated FAK-Rho GTPases signalling pathways. J. R. Soc. Interface9(67),313–327 (2012).
    • 48  Adams JC, Watt FM. Regulation of development and differentiation by the extracellular matrix. Development117(4),1183–1198 (1993).
    • 49  Sipehia R, Martucci G, Barbarosie M, Wu C. Enhanced attachment and growth of human endothelial cells derived from umbilical veins on ammonia plasma modified surfaces of PTFE and ePTFE synthetic vascular graft biomaterials. Biomat. Art. Cells Immob. Biotech.21(4),455–468 (1993).
    • 50  Gupta B, Plummer C, Bisson I, Frey P, Hilborn J. Plasma-induced graft polymerization of acrylic acid onto poly(ethylene terephthalate) films: characterization and human smooth muscle cell growth on grafted films. Biomaterials23(3),863–871 (2002).
    • 51  Crombez M, Chevallier P, Gaudreault RC, Petitclerc E, Mantovani D, Laroche G. Improving arterial prosthesis neo-endothelialization: application of a proactive VEGF construct onto PTFE surfaces. Biomaterials26(35),7402–7409 (2005).
    • 52  Chandy T, Das GS, Wilson RF, Rao GH. Use of plasma glow for surface-engineering biomolecules to enhance bloodcompatibility of Dacron and PTFE vascular prosthesis. Biomaterials21(7),699–712 (2000).
    • 53  Cao L, Sukavaneshvar S, Ratner BD, Horbett TA. Glow discharge plasma treatment of polyethylene tubing with tetraglyme results in ultralow fibrinogen adsorption and greatly reduced platelet adhesion. J. Biomed. Mater. Res. A79(4),788–803 (2006).
    • 54  Li F, Wang J, Sun H, Huang N. Surface characterization and in vitro blood compatibility of poly (ethylene terephthalate) immobilized with hirudin. Plasma Sci. Technol.12(2),235–239 (2010).
    • 55  Onder S, Kazmanli K, Kok FN. Alteration of PTFE surface to increase its blood compatibility. J. Biomat. Sci. Polym. Ed.22(11),1443–1457 (2011).
    • 56  Lotz A, Heller M, Brieger J, Gabriel M, Forch R. Derivatization of plasma polymerized thin films and attachment of biomolecules to influence HUVEC-cell adhesion. Plasma Processes Polym.9(1),10–16 (2012).
    • 57  Wise SG, Waterhouse A, Michael P, Ng MK. Extracellular matrix molecules facilitating vascular biointegration. J. Funct. Biomater.3,569–587 (2012).
    • 58  Kondyurin A, Bilek MM. Ion Beam Treatment of Polymers (1st Edition). Elsevier, Oxford, UK (2008).
    • 59  Bilek MM, Bax DV, Kondyurin A et al. Free radical functionalization of surfaces to prevent adverse responses to biomedical devices. Proc. Natl. Acad. Sci. USA108(35),14405–14410 (2011).▪▪ Describes the free radical-based mechanism of covalent binding to plasma-treated surfaces and includes a predictive model of the process.
    • 60  Hirsh SL, Bilek MM, Nosworthy NJ, Kondyurin A, Dos Remedios CG, Mckenzie DR. A comparison of covalent immobilization and physical adsorption of a cellulase enzyme mixture. Langmuir26(17),14380–14388 (2010).
    • 61  Nosworthy NJ, Ho JP, Kondyurin A, Mckenzie DR, Bilek MM. The attachment of catalase and poly-L-lysine to plasma immersion ion implantation-treated polyethylene. Acta Biomater.3,695–704 (2007).
    • 62  Bax DV, Mckenzie DR, Weiss AS, Bilek MM. Linker-free covalent attachment of the extracellular matrix protein tropoelastin to a polymer surface for directed cell spreading. Acta Biomater.5(9),3371–3381 (2009).
    • 63  Bax DV, Mckenzie DR, Weiss AS, Bilek MM. The linker-free covalent attachment of collagen to plasma immersion ion implantation treated polytetrafluoroethylene and subsequent cell-binding activity. Biomaterials31(9),2526–2534 (2010).
    • 64  Kondyurin A, Nosworthy NJ, Bilek MM. Attachment of horseradish peroxidase to polytetrafluorethylene (teflon) after plasma immersion ion implantation. Acta Biomater.4(5),1218–1225 (2008).
    • 65  Bax DV, Wang Y, Li Z et al. Binding of the cell adhesive protein tropoelastin to PTFE through plasma immersion ion implantation treatment. Biomaterials32(22),5100–5111 (2011).
    • 66  Bax DV, Mckenzie DR, Bilek MM, Weiss AS. Directed cell attachment by tropoelastin on masked plasma immersion ion implantation treated PTFE. Biomaterials32(28),6710–6718 (2011).
    • 67  Siow KS, Britcher L, Kumar S, Griesser HJ. Plasma methods for the generation of chemically reactive surfaces for biomolecule immobilization and cell colonization - a review. Plasma Processes Polym.3(6–7),392–418 (2006).▪ In-depth review of plasma processes including details on changes to surface chemistry and corresponding cellular interactions.
    • 68  Anders A. Metal plasma immersion ion implantation and deposition: a review. Surf. Coat. Tech.93(2–3),158–167 (1997).
    • 69  Desroches MJ, Omanovic S. Adsorption of fibrinogen on a biomedical-grade stainless steel 316LVM surface: a PM-IRRAS study of the adsorption thermodynamics, kinetics and secondary structure changes. Phys. Chem. Chem. Phys.10(18),2502–2512 (2008).
    • 70  Song SJ, Kim KS, Kim KH et al. Preparation of a biocompatible stent surface by plasma polymerization followed by chemical grafting of drug compounds. J. Mater. Chem.19(20),3248–3252 (2009).
    • 71  Gallino E, Massey S, Tatoulian M, Mantovani D. Plasma polymerized allylamine films deposited on 316L stainless steel for cardiovascular stent coatings. Surf. Coat. Tech.205(7),2461–2468 (2010).
    • 72  Yang Z, Wang J, Luo R et al. The covalent immobilization of heparin to pulsed-plasma polymeric allylamine films on 316L stainless steel and the resulting effects on hemocompatibility. Biomaterials31(8),2072–2083 (2010).
    • 73  Tang CJ, Wang GX, Shen Y et al. A study on surface endothelialization of plasma coated intravascular stents. Surf. Coat. Tech.204(9–10),1487–1492 (2010).
    • 74  Song SJ, Park YJ, Park J et al. Preparation of a drug-eluting stent using a TiO2 film deposited by plasma enhanced chemical vapour deposition as a drug-combining matrix. J. Mater. Chem.20(23),4792–4801 (2010).
    • 75  Yin Y, Nosworthy NJ, Youssef H, Gong B, Bilek MM, Mckenzie DR. Acetylene plasma coated surfaces for covalent immobilization of proteins. Thin Solid Films517(17),5343–5346 (2009).
    • 76  Yin Y, Bilek MM, Mckenzie DR et al. Acetylene plasma polymerized surfaces for covalent immobilization of dense bioactive protein monolayers. Surf. Coat. Tech.203(10–11),1310–1316 (2009).
    • 77  Yin Y, Wise SG, Nosworthy NJ et al. Covalent immobilisation of tropoelastin on a plasma deposited interface for enhancement of endothelialisation on metal surfaces. Biomaterials30,1675–1681 (2009).
    • 78  Waterhouse A, Yin YB, Wise SG et al. The immobilization of recombinant human tropoelastin on metals using a plasma-activated coating to improve the biocompatibility of coronary stents. Biomaterials31(32),8332–8340 (2010).
    • 79  Waterhouse A, Wise SG, Yin Y et al.In vivo biocompatibility of a plasma-activated, coronary stent coating. Biomaterials33,7984–7992 (2012).
    • 80  Ensinger W, Volz K. Thin film oxides as probe for homogeneity measurements of 3-dimensional objects treated by plasma immersion ion implantation. Nucl. Instrum. Meth.B166,154–158 (2000).
    • 81  Ensinger W, Volz K. Ion-beam assisted coating of tube inner walls by plasma immersion ion implantation. Surf. Coat. Tech.128,270–273 (2000).
    • 82  Xie D, Wan G, Maitz MF, Lei Y, Huang N, Sun H. Characterization and mechanical investigation of Ti–O2x film prepared by plasma immersion ion implantation and deposition for cardiovascular stents surface modification. Nucl. Instrum. Meth.B289,91–96 (2012).
    • 83  Kwok DTK, Schulz M, Hu T, Chu C, Chu P. Surface treatments of nearly equiatomic NiTi Alloy (Nitinol) for surgical implants, biomedical engineering. In: Trends in Materials Science. Laskovski AN (Ed.). InTech, Rijeka, Croatia (2011).
    • 84  Chen MC, Liang HF, Chiu YL, Chang Y, Wei HJ, Sung HW. A novel drug-eluting stent spray-coated with multi-layers of collagen and sirolimus. J. Control. Release108(1),178–189 (2005).
    • 85  Huang Y, Venkatraman SS, Boey FY et al.In vitro and in vivo performance of a dual drug-eluting stent (DDES). Biomaterials31(15),4382–4391 (2010).
    • 86  Basalus MW, Ankone MJ, van Houwelingen GK, de Man FH, von Birgelen C. Coating irregularities of durable polymer-based drug-eluting stents as assessed by scanning electron microscopy. Eurointervention5,157–165 (2009).
    • 87  Ostuka Y, Chronos NA, Apkarian RP, Robinson KA. Scanning electron microscopic analysis of defects in polymer coatings of three commercially available stents: comparison of BiodivYsio, Taxus and Cypher stents. J. Invasive Cardiol.19,71–76 (2007).
    • 88  Wiemer M, Butz T, Schmidt W, Schmitz KP, Horstkotte D, Langer C. Scanning electron microscopic analysis of different drug eluting stents after failed implantation: from nearly undamaged to major damaged polymers. Catheter. Cardiovasc. Interv.75(6),905–911 (2010).
    • 101  Kondyurin A, Maitz MF: WO022174 A3 (2007).